Hiroomi Tada - Sep 15, 2022 Form 4 Insider Report for Tyra Biosciences, Inc. (TYRA)

Role
Chief Medical Officer
Signature
/s/ Ali D. Fawaz, Attorney-in-Fact
Stock symbol
TYRA
Transactions as of
Sep 15, 2022
Transactions value $
$4,687
Form type
4
Date filed
9/19/2022, 06:20 PM
Previous filing
Sep 8, 2022
Next filing
Mar 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TYRA Common Stock Award $4.69K +612 +0.76% $7.66 81.2K Sep 15, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan.